Catechins containing a galloyl moiety as potential anti-HIV-1 compounds

被引:22
|
作者
Zhao, Yali [1 ]
Jiang, Fan [1 ]
Liu, Ping [1 ]
Chen, Wei [1 ]
Yi, Kejia [2 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Beijing 100853, Peoples R China
[2] Beijing Sci Technol & Management Coll, Beijing, Peoples R China
关键词
GREEN TEA CATECHINS; SEMEN-MEDIATED ENHANCEMENT; EPIGALLOCATECHIN-GALLATE; HIV-1; PROTEASE; REVERSE-TRANSCRIPTASE; CD4; POLYPHENOL; BINDING; REPLICATION; METABOLISM;
D O I
10.1016/j.drudis.2012.02.015
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Catechins containing galloyl moieties are important natural antioxidant compounds. In this paper, we review the multiple mechanisms whereby catechins containing a galloyl moiety can target key proteins to inhibit sexual transmission of HIV-1, as well as HIV-1 fusion, HIV-1 reverse transcriptase, HIV-1 integrase and HIV-1 protease. Furthermore, catechins with a galloyl moiety can mediate host cell factors such as nitric oxide synthase, nuclear factor-kappa B and casein kinase II to inhibit HIV-1 infection. The most significant inhibitory effect is blocking gp120 binding to isolated human CD4(+) T cells. The multiple mechanisms underlying the anti-HIV activity of galloyl-containing catechins predict that these catechins could be used as alternative therapies in the treatment of HIV infection.
引用
收藏
页码:630 / 635
页数:6
相关论文
共 50 条
  • [1] The evaluation of catechins that contain a galloyl moiety as potential HIV-1 integrase inhibitors
    Jiang, Fan
    Chen, Wei
    Yi, Kejia
    Wu, Zhiqiang
    Si, Yiling
    Han, Weidong
    Zhao, Yali
    CLINICAL IMMUNOLOGY, 2010, 137 (03) : 347 - 356
  • [2] HYDROXYCHLOROQUINE, A POTENTIAL ANTI-HIV-1 AGENT
    SPERBER, K
    LOUIE, M
    PRONER, J
    STECHER, V
    SAPIRA, E
    LIN, S
    MAYER, L
    FASEB JOURNAL, 1994, 8 (05): : A961 - A961
  • [3] RIBOZYMES AS POTENTIAL ANTI-HIV-1 THERAPEUTIC AGENTS
    SARVER, N
    CANTIN, EM
    CHANG, PS
    ZAIA, JA
    LADNE, PA
    STEPHENS, DA
    ROSSI, JJ
    SCIENCE, 1990, 247 (4947) : 1222 - 1225
  • [4] The role of the glycosyl moiety of myricetin derivatives in anti-HIV-1 activity in vitro
    Ortega, Joseph T.
    Suarez, Alirica I.
    Serrano, Maria L.
    Baptista, Jani
    Pujol, Flor H.
    Rangel, Hector R.
    AIDS RESEARCH AND THERAPY, 2017, 14
  • [5] The role of the glycosyl moiety of myricetin derivatives in anti-HIV-1 activity in vitro
    Joseph T. Ortega
    Alirica I. Suárez
    Maria L. Serrano
    Jani Baptista
    Flor H. Pujol
    Hector R. Rangel
    AIDS Research and Therapy, 14
  • [6] In vitro anti-HIV-1 activity of salicylidene acylhydrazide compounds
    Forthal, Donald N.
    Phan, Tran B.
    Slepenkin, Anatoly V.
    Landucci, Gary
    Chu, Hencelyn
    Elofsson, Mikael
    Peterson, Ellena
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2012, 40 (04) : 354 - 360
  • [7] A Review of FDA-Approved Anti-HIV-1 Drugs, Anti-Gag Compounds, and Potential Strategies for HIV-1 Eradication
    Sever, Belgin
    Otsuka, Masami
    Fujita, Mikako
    Ciftci, Halilibrahim
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (07)
  • [8] Anti-HIV-1 Antibodies
    Friedrich, M. J.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (03): : 227 - 227
  • [9] ANTI-HIV-1, CYTOTOXIC, AND BIOLOGICAL PROPERTIES OF SELECTED POLYOXOMETALATE COMPOUNDS
    HILL, CL
    WEEKS, M
    HARTNUP, M
    SOMMADOSSI, JP
    SCHINAZI, RF
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1990, 616 : 528 - 529
  • [10] Cytotoxic and anti-HIV-1 constituents of Gardenia obtusifolia and their modified compounds
    Tuchinda, P
    Pompimon, W
    Reutrakul, V
    Pohmakotr, M
    Yoosook, C
    Kongyai, N
    Sophasan, S
    Sujarit, K
    Upathum, SE
    Santisuk, T
    TETRAHEDRON, 2002, 58 (40) : 8073 - 8086